Definitive Contract W91YTZ23C0010

Award Date 10/1/23
Potential Completion Date 9/30/28
Potential Value $600K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Fort Eisenhower, GA 30905, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products, reagents, and equipment for blood transfusion and transplantation compatibility testing. The contract, valued at $535,165.00, is for the delivery of two blood bank automated analyzers to support the Pathology Department at William Beaumont Army Medical Center at Fort Bliss, Texas. The contract term is from October 1, 2023,...
Immucor Inc. has been awarded a $59,188.35 delivery order against its Federal Supply Schedule contract for blood bank reagents. The contract calls for Immucor to provide blood typing, compatibility testing, antibody screening, and other critical reagents to support the blood banking operations of the Defense Health Agency. Performance will take place in Norcross, Georgia through September 30, 2023. As the prime contractor for this delivery order, Immucor will leverage its expertise in...
This is a firm fixed-price contract awarded to Immucor Inc. by the Defense Health Agency, a component of the Department of Defense, to provide blood bank analyzers, reagents, tools, materials, training, supplies, consumables, and maintenance services to support the Department of Pathology at Martin Army Community Hospital at Fort Benning, Georgia. The contract has a ceiling value of $837,274.12 and a period of performance through September 30, 2025. The solicitation did not use a set-aside...
This is a delivery order awarded to Immucor Inc. under the Defense Health Agency's federal contract vehicle. The $17,097.60 firm fixed price order is for the supply of blood bank reagents to support the agency's blood transfusion and immunohematology testing programs. The ultimate completion date for this order is September 30, 2025. Immucor is a leading manufacturer of automated in vitro diagnostic systems and consumables for blood typing and compatibility testing used in medical facilities,...
The Defense Health Agency awarded a firm-fixed-price purchase order to Immucor Inc., a for-profit manufacturer of goods, for the delivery of blood typing reagents. The $228,353.45 contract has an ultimate completion date of September 30, 2027. Immucor has previously provided a variety of in vitro diagnostic products, reagents, test kits, and blood banking supplies to federal agencies such as the Department of Veterans Affairs and the Indian Health Service. This award is not set aside and is...
This is a firm-fixed price purchase order contract awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostics, reagents, and blood banking supplies. The $514,572.15 contract is for the delivery of unspecified supplies, with a period of performance ending on September 30, 2023. No set-aside designation was used. Immucor is an experienced federal contractor, having previously provided a variety of medical products and services to agencies such as the...
This is a firm fixed-price delivery order contract awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products. The contract, valued at $403,914.14, is for the provision of specialized medical supplies such as blood bank analyzers, reagents, test kits, and related consumables. The contract is issued under the General Services Administration (GSA) Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests, and has an ultimate completion...
This federal contract award to Immucor Inc. is for the delivery of REAGENTS to support blood banking and transfusion compatibility testing at the Department of the Army Medical Command facility in Fort Stewart, Georgia. The $177,302.39 firm fixed price purchase order was issued on April 1, 2019, with a completion date of September 30, 2020. The original solicitation called for blood bank analyzers and reagents, and the award to Immucor, a for-profit manufacturer, does not have a set-aside...
This is a federal contract award to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products, reagents, and equipment for blood transfusion and transplantation compatibility testing. The contract, valued at $284,315.40, is a Firm Fixed Price Delivery Order for a "Blood Bank Analyzer" awarded by the Veterans Integrated Service Network 7, a civilian agency within the Department of Veterans Affairs. The contract has no set-aside designation and a period of performance...
This is a $61,238.20 firm fixed price purchase order contract awarded by the Defense Health Agency (DHA) to Immucor Inc. for the delivery of blood bank reagents. The contract has an ultimate completion date of October 1, 2027. Immucor, a manufacturer of in vitro diagnostic products for transfusion and transplantation testing, was awarded this sole source contract under FAR 13.106-1 based on its specialized capabilities and proprietary solutions. The contract is not associated with a federal...

The U.S. Defense Health Agency awarded a $600,045 firm fixed price definitive contract to Immucor Inc. to provide a blood bank analyzer, reagents, data management system, training, and maintenance services to the Dwight D. Eisenhower Army Medical Center in Fort Gordon, Georgia. This contract was not set aside and has a potential period of performance from October 2023 to September 2028, depending on the exercise of optional one-year extensions. Immucor is a leading provider of automated instrument-reagents systems and consumables for blood transfusion and transplantation compatibility testing, and has previously supported the in vitro diagnostic and medical supply needs of federal agencies including the Department of Veterans Affairs and the Indian Health Service.

Generated 2/14/25, 9:21 AM